DEFECTIVE TRAFFICKING OF RHODOPSIN AND ITS ROLE IN RETINAL DEGENERATIONS

被引:54
作者
Hollingsworth, T. J. [1 ]
Gross, Alecia K. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL USA
[2] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL USA
来源
INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 293 | 2012年 / 293卷
关键词
Retinitis pigmentosa; Rhodopsin; Mislocalization; Retinal degeneration; Bardet-Biedl syndrome; Usher syndrome; Leber's congenital amaurosis; DOMINANT RETINITIS-PIGMENTOSA; BARDET-BIEDL-SYNDROME; INTRAFLAGELLAR TRANSPORT PROTEIN; LEBER CONGENITAL AMAUROSIS; SPLICING-FACTOR GENES; AGE-RELATED-CHANGES; CGMP-GATED CHANNEL; USHER-SYNDROME; MOUSE MODEL; CELL-DEATH;
D O I
10.1016/B978-0-12-394304-0.00006-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Retinitis pigmentosa is a retinal degeneration transmitted by varied modes of inheritance and affects approximately 1 in 4000 individuals. The photoreceptors of the outer retina, as well as the retinal pigmented epithelium which supports the outer retina metabolically and structurally, are the retinal regions most affected by the disorder. In several forms of retinitis pigmentosa, the mislocalization of the rod photoreceptor protein rhodopsin is thought to be a contributing factor underlying the pathophysiology seen in patients. The mutations causing this mislocalization often occur in genes coding proteins involved in ciliary formation, vesicular transport, rod outer segment disc formation, and stability, as well as the rhodopsin protein itself. Often, these mutations result in the most early-onset cases of both recessive and dominant retinitis pigmentosa, and the following presents a discussion of the proteins, their degenerative phenotypes, and possible treatments of the disease.
引用
收藏
页码:1 / 44
页数:44
相关论文
共 245 条
[1]   Impaired photoreceptor protein transport and synaptic transmission in a mouse model of Bardet-Biedl syndrome [J].
Abd-El-Barr, Muhammad M. ;
Sykoudis, Kristen ;
Andrabi, Sara ;
Eichers, Erica R. ;
Pennesi, Mark E. ;
Tan, Perciliz L. ;
Wilson, John H. ;
Katsanis, Nicholas ;
Lupski, James R. ;
Wu, Samuel M. .
VISION RESEARCH, 2007, 47 (27) :3394-3407
[2]  
ABRAMS JM, 1993, DEVELOPMENT, V117, P29
[3]   Modulation of GDP release from transducin by the conserved Glu(134)-Arg(135) sequence in rhodopsin [J].
Acharya, S ;
Karnik, SS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (41) :25406-25411
[4]   Gene therapy restores vision in a canine model of childhood blindness [J].
Acland, GM ;
Aguirre, GD ;
Ray, J ;
Zhang, Q ;
Aleman, TS ;
Cideciyan, AV ;
Pearce-Kelling, SE ;
Anand, V ;
Zeng, Y ;
Maguire, AM ;
Jacobson, SG ;
Hauswirth, WW ;
Bennett, J .
NATURE GENETICS, 2001, 28 (01) :92-95
[5]   Rod and cone opsin mislocalization in an autopsy eye from a carrier of X-linked retinitis pigmentosa with a Gly436Asp mutation in the RPGR gene [J].
Adamian, Michael ;
Pawlyk, Basil S. ;
Hong, Dong-Hyun ;
Berson, Eliot L. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (03) :515-518
[6]   Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F [J].
Ahmed, ZM ;
Riazuddin, S ;
Bernstein, SL ;
Ahmed, Z ;
Khan, S ;
Griffith, AJ ;
Morell, RJ ;
Friedman, TB ;
Riazuddin, S ;
Wilcox, ER .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (01) :25-34
[7]   The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene [J].
Alagramam, KN ;
Murcia, CL ;
Kwon, HY ;
Pawlowski, KS ;
Wright, CG ;
Woychik, RP .
NATURE GENETICS, 2001, 27 (01) :99-102
[8]   Activation of mislocalized opsin kills rod cells: A novel mechanism for rod cell death in retinal disease [J].
Alfinito, PD ;
Townes-Anderson, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5655-5660
[9]   Gene therapy in the second eye of RPE65-deficient dogs improves retinal function [J].
Annear, M. J. ;
Bartoe, J. T. ;
Barker, S. E. ;
Smith, A. J. ;
Curran, P. G. ;
Bainbridge, J. W. ;
Ali, R. R. ;
Petersen-Jones, S. M. .
GENE THERAPY, 2011, 18 (01) :53-61
[10]  
Apfelstedt-Sylla E, 1992, Ger J Ophthalmol, V1, P319